Get 20M+ Full-Text Papers For Less Than $1.50/day. Subscribe now for You or Your Team.

Learn More →

EGFR tyrosine kinase inhibitors for the treatment of NSCLC in East Asia: present and future.

EGFR tyrosine kinase inhibitors for the treatment of NSCLC in East Asia: present and future. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Lung Cancer Pubmed

EGFR tyrosine kinase inhibitors for the treatment of NSCLC in East Asia: present and future.

Lung Cancer , Volume 60 Suppl 2: 8 – Oct 2, 2008

EGFR tyrosine kinase inhibitors for the treatment of NSCLC in East Asia: present and future.

Lung Cancer , Volume 60 Suppl 2: 8 – Oct 2, 2008

Loading next page...
 
/lp/pubmed/egfr-tyrosine-kinase-inhibitors-for-the-treatment-of-nsclc-in-east-13bPv29Rpg

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0169-5002
DOI
10.1016/S0169-5002(08)70102-8
pmid
18513581

Abstract

Journal

Lung CancerPubmed

Published: Oct 2, 2008

There are no references for this article.